Categories
- Administrative law (3,493)
- Admiralty-Maritime Law (2,514)
- Advertising Law (2,069)
- Antitrust – Competition law (735)
- Aviation Law (959)
- Banking and Finance law (1,951)
- Bankruptcy Law (1,397)
- Business law (2,076)
- Constitutional Law (688)
- Contract Law (44)
- Copyright Law (1,415)
- Corporate Law (1,455)
- Criminal Law (1,149)
- Divorce Law (2,187)
- Elder Law (117)
- Employment and Labour Law (1,216)
- Environmental Law (653)
- Estate Planning (691)
- Family Law (1,070)
- General Legal News (225)
- Health Law (1,261)
- Immigration law (883)
- Injury & Accident Law (1,390)
- Insurance (664)
- Intellectual Property (1,357)
- International Law (569)
- Judiciary (562)
- Law Librarians (1,800)
- Law Professors (1,118)
- Law Students (993)
- Legal Ethics (306)
- Legal Marketing (1,086)
- Legal Theory (707)
- Medical malpractice law (1,204)
- Products Liability (847)
- Real Estate & Property Law (938)
- Securities Law (732)
- Seogpst (2)
- Tax Law (1,059)
- Technology & Cyberlaw (1,526)
- World (729)
- Germany (3)
- Writings and Citations (4)
Tag Archives: DPP4
Diabetes Medicines In DPP-4 Inhibitor Class Might Not Increase Risk Of Inflammatory Bowel Disease (IBD)
But New Medical Study Finds That Januvia, Onglyza, Other Drugs In Class Significantly Increase Risk Of Crohn's Disease (CD) (Posted by Tom Lamb at DrugInjuryWatch.com) Back in March 2018 we wrote this report, "Januvia, Onglyza, And Certain Other … Continue reading
Posted in Health Law
Tagged Bowel, class, DIABETES, Disease, DPP4, IBD , increase, inflammatory, Inhibitor, Medicines, might, Risk
Leave a comment
Diabetes Drugs In DPP-4 Inhibitor Class Associated With Almost Two-Times Increased Risk of Cholangiocarcinoma
Medical Researchers Finding This Rare But Highly Fatal Cancer Call For More Investigation Into This Possible Drug Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) A recent medical study shows that the use of diabetes medicines in the … Continue reading
Posted in Injury & Accident Law
Tagged Almost, Associated, Cholangiocarcinoma, class, DIABETES, DPP4, Drugs, Increased, Inhibitor, Risk, TwoTimes
Leave a comment
DPP-4 Diabetes Drug Side Effects Include Heart Attacks And Strokes As Well As Heart Failure
Onglyza, Nesina, Januvia, and Tradjenta Are Included In This Popular Class Of Type-2 Diabetes Medications (Posted by Tom Lamb at DrugInjuryWatch.com) In April 2016 the FDA took regulatory action by mandating label changes with new warnings about an … Continue reading